Rhenman & Partners Asset Management’s Moderna MRNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,000	Closed	-$3.1M	–	91
2023 Q3	$3.1M	Sell	30,000 -15,000	-33%	-$1.55M	0.33%	64
2023 Q2	$5.47M	Buy	+45,000	New	+$5.47M	0.58%	54